Glucosidase Activator

Cat.No. Product Name Information Product Use Citations Product Validations
S1024 LTI-291 LTI-291 is the first small-molecule activator of Glucocerebrosidase(GCase) for the treatment of parkinson's disease.
Experimental and Molecular Medicine, September 2022, 1536-1548
Experimental and Molecular Medicine, 2022, 1536-1548
Exp Mol Med, 2022, 54-9:1536-1548